Jörn Glökler

Jörn Glökler

Auto-generated profile, based on publicly available information

Jörn Glökler

HS Diagnomics GmbH, Berlin, Germany

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2002 in Analytical Biochemistry
Verified
Journal Article
Closed access
PAPhilipp Angenendt
Philipp Angenendt
JGJörn Glökler
Jörn Glökler
DMDerek Murphy
Derek Murphy
HLHans Lehrach
Hans Lehrach
DCDolores J Cahill
Dolores J Cahill

29 December 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TSTatjana Schütze
Tatjana Schütze
BWBarbara Wilhelm
Barbara Wilhelm
NGNicole Greiner
Nicole Greiner
HBHannsjörg Braun
Hannsjörg Braun
FPFranziska Peter
Franziska Peter
JGJörn Glökler
Jörn Glökler
SELEX is an iterative process in which highly diverse synthetic nucleic acid libraries are selected over many rounds to finally identify aptamers with desired properties. However, little is understood as how binders are enriched during the selection course. Next-generation sequencing offers the opportunity to open the black box and observe a large part of the population dynamics during the selection process. We have performed a semi-automated SELEX procedure on the model target streptavidin starting with a synthetic DNA oligonucleotide library and compared results obtained by the conventional analysis via cloning and Sanger sequencing with next-generation sequencing. In order to follow the population dynamics during the selection, pools from all selection rounds were barcoded and sequenced in parallel. High affinity aptamers can be readily identified simply by copy number enrichment in the first selection rounds. Based on our results, we suggest a new selection scheme that avoids a high number of iterative selection rounds while reducing time, PCR bias, and artifacts.

15 July 2021 in Critical Reviews in Biochemistry and Molecular Biology
Verified
Journal Article
Open access
JGJörn Glökler
Jörn Glökler
TLTheam Soon Lim
Theam Soon Lim
JIJeunice Ida
Jeunice Ida
MFMarcus Frohme
Marcus Frohme
The introduction of nucleic acid amplification techniques has revolutionized the field of medical diagnostics in the last decade. The advent of PCR catalyzed the increasing application of DNA, not just for molecular cloning but also for molecular based diagnostics. Since the introduction of PCR, a deeper understanding of molecular mechanisms and enzymes involved in DNA/RNA replication has spurred the development of novel methods devoid of temperature cycling. Isothermal amplification methods have since been introduced utilizing different mechanisms, enzymes, and conditions. The ease with which isothermal amplification methods have allowed nucleic acid amplification to be carried out has had a profound impact on the way molecular diagnostics are being designed after the turn of the millennium. With all the advantages isothermal amplification brings, the issues or complications surrounding each method are heterogeneous making it difficult to identify the best approach for an end-user. This review pays special attention to the various isothermal amplification methods by classifying them based on the mechanistic characteristics which include reaction formats, amplification information, promoter, strand break, and refolding mechanisms. We would also compare the efficiencies and usefulness of each method while highlighting the potential applications and detection methods involved. This review will serve as an overall outlook on the journey and development of isothermal amplification methods as a whole.

3 April 2015 in BioTechniques
Verified
Journal Article
Open access
JFJens Fischbach
Jens Fischbach
NXNina Carolin Xander
Nina Carolin Xander
MFMarcus Frohme
Marcus Frohme
JGJörn Felix Glökler
Jörn Felix Glökler
The need for simple and effective assays for detecting nucleic acids by isothermal amplification reactions has led to a great variety of end point and real-time monitoring methods. Here we tested direct and indirect methods to...

1 September 2016 in Applied & Translational Genomics
Verified
Journal Article
Open access
CEChristoph Endrullat
Christoph Endrullat
JGJörn Glökler
Jörn Glökler
PFPhilipp Franke
Philipp Franke
MFMarcus Frohme
Marcus Frohme
DNA sequencing continues to evolve quickly even after > 30 years. Many new platforms suddenly appeared and former established systems have vanished in almost the same manner. Since establishment of next-generation sequencing devices, this progress gains momentum due to the continually growing demand for higher throughput, lower costs and better quality of data. In consequence of this rapid development, standardized procedures and data formats as well as comprehensive quality management considerations are still scarce. Here, we listed and summarized current standardization efforts and quality management initiatives from companies, organizations and societies in form of published studies and ongoing projects. These comprise on the one hand quality documentation issues like technical notes, accreditation checklists and guidelines for validation of sequencing workflows. On the other hand, general standard proposals and quality metrics are developed and applied to the sequencing workflow steps with the main focus on upstream processes. Finally, certain standard developments for downstream pipeline data handling, processing and storage are discussed in brief. These standardization approaches represent a first basis for continuing work in order to prospectively implement next-generation sequencing in important areas such as clinical diagnostics, where reliable results and fast processing is crucial. Additionally, these efforts will exert a decisive influence on traceability and reproducibility of sequence data.

1 August 2003 in Journal of Chromatography A
Verified
Journal Article
Closed access
PAPhilipp Angenendt
Philipp Angenendt
JGJörn Glökler
Jörn Glökler
JSJens Sobek
Jens Sobek
HLHans Lehrach
Hans Lehrach
DCDolores J. Cahill
Dolores J. Cahill